About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | LONGitudinal Multi-omics Phenotyping of KIDney Function Alteration

LONGitudinal Multi-omics Phenotyping of KIDney Function Alteration

NCT05570929·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Hendrik Bartolomaeus, MD
CONTACT
+49 30 450 540 464 hendrik.bartolomaeus@charite.de

Lead

Charite University, Berlin, Germany

Age

18–75

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Body-Mass-Index 18,5 - 34,9 kg/m2
Planned living kidney donation / transplantation

You may not be if

Clinically relevant heart, lung, liver, and kidney diseases
Postoperative phase
Acute infections
Vegan diet
Change of body weight of more than 10% in the month prior to study entry
Known drug or alcohol abuse

The record

StatusRecruiting

PhaseNo phase

Taking part20

StartedFeb 2023

UpdatedJul 1, 2024

Conditions

Chronic Kidney Diseases

Where1

Experimental and Clinical Research Center
Berlin, Germany